| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0018 | 1 |